Markets:

Overview

News

Currencies

International

Treasuries

Artelo Biosciences, Inc. - Common Stock (NQ:ARTL)

7.985 +0.405 (+5.34%)

Streaming Delayed Price Updated: 9:59 AM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Artelo Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Artelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain ↗

June 27, 2023

Professor Saoirse O’Sullivan, vice president of translational sciences at Artelo Biosciences, Inc.

Via Benzinga

Artelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In Canada ↗

June 26, 2023

Artelo Biosciences, Inc.

Via Benzinga

Artelo Biosciences: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 28, 2023

Via Benzinga

Artelo Enters Next Phase Of Evaluation Of Its Cannabinoid Receptor Targeting Drug For The Treatment Of Cancer-Related Anorexia And Weight Loss ↗

April 26, 2023

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 17, 2023

Via Benzinga

Recap: Artelo Biosciences Q2 Earnings ↗

May 12, 2022

Artelo Biosciences (NASDAQ:ARTL) reported its Q2 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket ↗

December 22, 2022

Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket ↗

August 23, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 23, 2022

Good morning! It's time for a breakdown of the biggest pre-market stock movers for Tuesday and the news that has them moving.

Via InvestorPlace

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 17, 2022

Via Benzinga

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗

August 17, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...

Via Benzinga

U.S. Stocks Open Lower; Nasdaq Down 150 Points ↗

August 17, 2022

U.S. stocks traded lower this morning, with the Nasdaq composite dropping more than 150 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 17, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 17, 2022

We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning!

Via InvestorPlace

Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket ↗

August 17, 2022

Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.

Via Benzinga

This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday ↗

August 17, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 16, 2022

Via Benzinga

Nasdaq Falls 75 Points; Ventyx Biosciences Shares Spike Higher ↗

August 16, 2022

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 75 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 16, 2022

Via Benzinga

Dow Jumps Over 200 Points; Crude Oil Falls Sharply ↗

August 16, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.

Via Benzinga

Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session ↗

August 16, 2022

Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.

Via Benzinga

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 10, 2022

Gainers

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗

July 19, 2022

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 13, 2022

Gainers

Via Benzinga

Artelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced Pain ↗

June 27, 2022

Professor Saoirse O’Sullivan, vice president of translational sciences at Artelo Biosciences Inc., (NASDAQ: ARTL) presented new research results entitled, “Discovery and pre

Via Benzinga

Artelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th

May 13, 2022

SOLANA BEACH, CA / ACCESSWIRE / May 13, 2022 / Artelo Biosciences, Inc. "Artelo" or the "Company") (NASDAQ:ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate...

From Artelo Biosciences, Inc.

Via AccessWire

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

May 16, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...

From MicroCap Rodeo

Via AccessWire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.